MONTGOMERY, Ala. - (Mealey's) An 8-1 majority of the Alabama Supreme Court on Jan. 11 ruled that Wyeth can be held liable for failing to warn doctors about the risk of long-term use of Reglan if a patient was injured by metoclopramide, the generic... Read More
SAN FRANCISCO - (Mealey's) Pharmacies have standing to pursue unfair competition law (UCL) claims alleging that they paid higher prices because of price fixing by pharmaceutical companies, even though they passed the higher prices on to consumers... Read More
ROSELAND, N.J. - Carella, Byrne, Cecchi, Olstein, Brody & Agnello P.C. on June 29 announced that a securities class action lawsuit was filed on June 18 in the U.S. District Court for the District of New Jersey on behalf of purchasers of Wyeth Inc... Read More
BOSTON — (Mealey’s) A Massachusetts federal jury on March 25 awarded $47.3 million to the Kaiser Foundation after finding that Pfizer Inc. engaged in racketeering and unfair competition through its off-label marketing of Neurontin ( In Re... Read More